Israel Englander Navidea Biopharmaceuticals, Inc. Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.24 - $0.34 $30,901 - $43,777
128,756 New
128,756 $33,000
Q3 2022

Nov 14, 2022
BUY
$0.24 - $0.71 $9,635 - $28,503
40,146 New
40,146 $10,000

Others Institutions Holding NAVB

# of Institutions
3
Shares Held
10.4K
Call Options Held
0
Put Options Held
0
View Full List

About NAVIDEA BIOPHARMACEUTICALS, INC.

NAVB Quotes by TradingView
  • Ticker NAVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,150,900
  • Description
  • Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...
More about NAVB
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email